Bausch Health Co. Inc. (BHC) Misses Q1 EPS, Revenue
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/21/2026
- Wall Street rallies as AI optimism reignites and Treasury yields retreat
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Oil price dips to $100 on hopes of US-Iran diplomacy, partial recovery in Saudi exports
- Paramount, Warner Bros jump on report of settlement progress in merger fight
- Investors may be underpricing how far rate hikes could go, Deutsche says
- Far-left party wins Berlin election, pledging to nationalise housing
- Cybercrime feud erupts on dark web as notorious group claims hijack of rival's website
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Qatar Investment Authority targets $20B partnership with JPMorgan - Bloomberg
- Wall Street rallies as AI optimism reignites and Treasury yields retreat
Bausch Health Companies Inc. Announces First-Quarter 2022 Results
May 10, 2022 6:59 AM EDTFirst-Quarter 2022 Financial ResultsRevenues of $1.918 BillionGAAP Net Loss of $69 MillionAdjusted EBITDA (non-GAAP)1Â of $732 Million Bausch + Lomb Commences Trading Under "BLCO" Ticker Following IPO2Updates Full-Year Revenue and Adjusted EBITDA (non-GAAP)1 Guidance Ranges
LAVAL, QC, May 10, 2022 /PRNewswire/ -- Bausch Health Companies Inc. (NYSE/TSX: BHC) ("Bausch Health" or the "Company" or "we") today announced its first-quarter 2022 financial results.
"Our organic3Â growth in the first quarter of 2022 was stable compared to the same quarter... More
